Monjuvi contains the monoclonal antibody Tafasitamab-cxix, which is designed to bind to targets found on specific types of cancer cells. These antibodies work in a variety of ways, such as stimulating the immune system to destroy cells, preventing cell growth or essential cell functions. However, using Monjuvi cs can cause some side effects. Therefore, patients need to carefully review the information of the drug before using it, and at the same time must follow the instructions of the doctor.

Tafasitamab-cxix or Monjuvi is a prescription medicine used to treat diffuse large B-cell lymphoma (DLBCL), a type of non-hodgkin lymphoma. Tafasitamab-cxix should only be used as ordered and directed by your doctor. Do not arbitrarily use to avoid encountering risks.